Skip to main content
Erschienen in: Clinical Research in Cardiology 12/2008

01.12.2008 | ORIGINAL PAPER

Reverse remodelling through exercise training is more pronounced in non-ischemic heart failure

verfasst von: Charles Delagardelle, MD, Patrick Feiereisen, MSc, Michel Vaillant, PhD, Georges Gilson, PhD, Yves Lasar, MD, Jean Beissel, MD, Daniel R. Wagner, MD, PhD

Erschienen in: Clinical Research in Cardiology | Ausgabe 12/2008

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Most training studies in patients with chronic heart failure (CHF) do not consider CHF aetiology in the interpretation of the results. About 60% of the patients in those studies have ischemic CHF (IHF) and 40% non-ischemic CHF (NHF). Recently, we conducted a randomized controlled trial to study three different training modalities in 60 patients with severe CHF, with a similar distribution of IHF and NHF patients. In the present post hoc analysis we compared the differences in training results between ischemic and non-ischemic patients.

Methods

Left ventricular ejection fraction (EF), end diastolic volume (EDV), end systolic volume (ESV), measured with radionuclide ventriculography (RNV) and echocardiography, NT-pro BNP, peak oxygen uptake (peak \(V_{{{\rm O}_{2} }} \)), working capacity and muscular volume were analyzed before and after training in 45 patients training for 40 sessions, 3 times per week. Fifteen patients served as control group. The outcome was analyzed considering the aetiology of CHF, either ischemic or non-ischemic.

Results

There were no significant differences in improvements of peak \(V_{{{\rm O}_{2} }}\), working capacity and muscular volume between IHF and NHF patients. In NHF patients, EF increased while EDV and ESV decreased after training. These parameters remained unchanged in IHF patients after training. NT-pro BNP decreased significantly in NHF patients and increased in IHF patients after training. In the control group, patients showed a mild improvement of EF and a decrease of NT-pro BNP.

Conclusion

This post hoc analysis shows that training intervention is associated with significant reverse remodelling in NHF, but not in IHF patients, whereas \( V_{{{\rm O}_{2} }} \) peak and muscle volume improve regardless of CHF aetiology. Future prospective studies are needed to confirm our findings.
Literatur
1.
Zurück zum Zitat Anand IS, Fisher LD, Chiang YT et al (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-Heft). Circulation 107:1278–1283PubMedCrossRef Anand IS, Fisher LD, Chiang YT et al (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-Heft). Circulation 107:1278–1283PubMedCrossRef
2.
Zurück zum Zitat Bart BA, Shaw LK, McCants CB Jr (1997) Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 30:1002–1008PubMedCrossRef Bart BA, Shaw LK, McCants CB Jr (1997) Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 30:1002–1008PubMedCrossRef
3.
Zurück zum Zitat Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–2150PubMedCrossRef Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–2150PubMedCrossRef
4.
Zurück zum Zitat Cicoira M, Zanolla L, Franceschini L, Rossi A, Golia G, Zamboni M, Tosoni P, Zardini P (1999) Skeletal muscle mass independently predicts peak oxygen consumption in non cachectic patients with chronic heart failure. Circulation 99:1138–1140 Cicoira M, Zanolla L, Franceschini L, Rossi A, Golia G, Zamboni M, Tosoni P, Zardini P (1999) Skeletal muscle mass independently predicts peak oxygen consumption in non cachectic patients with chronic heart failure. Circulation 99:1138–1140
5.
Zurück zum Zitat Coats AJS (1999) Exercise training for heart failure coming of age. Circulation 99:1138–1140PubMed Coats AJS (1999) Exercise training for heart failure coming of age. Circulation 99:1138–1140PubMed
6.
Zurück zum Zitat Conraads VM, Beckers P, Vaes J et al (2004) Combined endurance/resistance training reduces NT-pro BNP levels in patients with chronic heart failure. Eur Heart J 25:1797–1805PubMedCrossRef Conraads VM, Beckers P, Vaes J et al (2004) Combined endurance/resistance training reduces NT-pro BNP levels in patients with chronic heart failure. Eur Heart J 25:1797–1805PubMedCrossRef
7.
Zurück zum Zitat Delagardelle C, Feiereisen P, Autier P et al (2002) Strength/endurance training versus endurance training in congestive heart failure. Med Sci Sports Exerc 34:1868–1872PubMedCrossRef Delagardelle C, Feiereisen P, Autier P et al (2002) Strength/endurance training versus endurance training in congestive heart failure. Med Sci Sports Exerc 34:1868–1872PubMedCrossRef
8.
Zurück zum Zitat European heart failure training group (1998) Experience from controlled trials of physical training in chronic heart failure. Eur Heart J 19:466–475CrossRef European heart failure training group (1998) Experience from controlled trials of physical training in chronic heart failure. Eur Heart J 19:466–475CrossRef
9.
Zurück zum Zitat Feiereisen P, Delagardelle C, Vaillant M, Lasar Y, Beissel J (2007) Is strength training the more efficient training modality in chronic heart failure? Med Sci Sports Exerc 39:1910–1917PubMed Feiereisen P, Delagardelle C, Vaillant M, Lasar Y, Beissel J (2007) Is strength training the more efficient training modality in chronic heart failure? Med Sci Sports Exerc 39:1910–1917PubMed
10.
Zurück zum Zitat Felker GM, Thompson RE, Hare JM et al (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopthy. N Engl J Med 342:1077–1084PubMedCrossRef Felker GM, Thompson RE, Hare JM et al (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopthy. N Engl J Med 342:1077–1084PubMedCrossRef
11.
Zurück zum Zitat Follath F, Cleland JGF, Klein W, Murphy R (1998) Aetiology and response to drug treatment in heart failure. J Am Coll Cardiol 32:1167–1172PubMedCrossRef Follath F, Cleland JGF, Klein W, Murphy R (1998) Aetiology and response to drug treatment in heart failure. J Am Coll Cardiol 32:1167–1172PubMedCrossRef
12.
Zurück zum Zitat Goetze JP (2005) Coronary artery disease, heart failure and cardiac natriuretic peptides in the middle. Eur Heart J 26:2603–2604PubMedCrossRef Goetze JP (2005) Coronary artery disease, heart failure and cardiac natriuretic peptides in the middle. Eur Heart J 26:2603–2604PubMedCrossRef
13.
Zurück zum Zitat Hambrecht R, Gielen S, Linke A et al (2000) Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: a randomized trial. JAMA 283:3095–30101PubMedCrossRef Hambrecht R, Gielen S, Linke A et al (2000) Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: a randomized trial. JAMA 283:3095–30101PubMedCrossRef
14.
Zurück zum Zitat Haykowsky MJ, Yuanyuan L, Pechter D et al (2007) A meta.analysis of the effect of exercise training on left ventricular remodeling in heart failure patients. J Am Coll Cardiol 49:2329–2333PubMedCrossRef Haykowsky MJ, Yuanyuan L, Pechter D et al (2007) A meta.analysis of the effect of exercise training on left ventricular remodeling in heart failure patients. J Am Coll Cardiol 49:2329–2333PubMedCrossRef
15.
Zurück zum Zitat Iwanaga Y, Nishi I, Furuichi S et al (2006) B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure. J Am Coll Cardiol 47:742–748PubMedCrossRef Iwanaga Y, Nishi I, Furuichi S et al (2006) B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure. J Am Coll Cardiol 47:742–748PubMedCrossRef
16.
Zurück zum Zitat Kragelund C, Gronning B, Kober L et al (2005) N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352:666–675PubMedCrossRef Kragelund C, Gronning B, Kober L et al (2005) N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352:666–675PubMedCrossRef
17.
Zurück zum Zitat Maron BJ (ed) (2006) AHA scientific statement contemporary definitions and classification of the cardiomyopathies. Circulation 113:1807–1816 Maron BJ (ed) (2006) AHA scientific statement contemporary definitions and classification of the cardiomyopathies. Circulation 113:1807–1816
18.
Zurück zum Zitat Mc Kelvie RS, Teo KK, Roberts R et al (2002) Effects of exercise training in patients with heart failure: the exercise rehabilitation trial (EXERT). Am Heart J 144: 23–30CrossRef Mc Kelvie RS, Teo KK, Roberts R et al (2002) Effects of exercise training in patients with heart failure: the exercise rehabilitation trial (EXERT). Am Heart J 144: 23–30CrossRef
19.
Zurück zum Zitat Navarro Estrada JL, Rubinstein F et al (2006) NT-probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non-ST elevation acute coronary syndromes. Am Heart J 151:1093–1105PubMed Navarro Estrada JL, Rubinstein F et al (2006) NT-probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non-ST elevation acute coronary syndromes. Am Heart J 151:1093–1105PubMed
20.
Zurück zum Zitat Passino C, Severino S, Poletti R et al (2006) Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol 47:1835–1839PubMedCrossRef Passino C, Severino S, Poletti R et al (2006) Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol 47:1835–1839PubMedCrossRef
21.
Zurück zum Zitat Piepoli MF, Davos C, Francis DP, Coats AJS (2004) Exercise training meta-analysis of trials in patients with chronic heart failure (ExTtraMATCH). BMJ 328:189–192PubMedCrossRef Piepoli MF, Davos C, Francis DP, Coats AJS (2004) Exercise training meta-analysis of trials in patients with chronic heart failure (ExTtraMATCH). BMJ 328:189–192PubMedCrossRef
22.
Zurück zum Zitat Shephard RJ (1996) Exercise for patients with congestive heart failure. Sports Med 23:75–92CrossRef Shephard RJ (1996) Exercise for patients with congestive heart failure. Sports Med 23:75–92CrossRef
23.
Zurück zum Zitat Webb-Peploe K, Chua TP, Harrington D, Henein MY, Gibson DG, Coats AJS (2000) Different response of patients with idiopathic and ischaemic dilated cardiomyopathy to exercise training. Int J Cardiol 74:215–224PubMedCrossRef Webb-Peploe K, Chua TP, Harrington D, Henein MY, Gibson DG, Coats AJS (2000) Different response of patients with idiopathic and ischaemic dilated cardiomyopathy to exercise training. Int J Cardiol 74:215–224PubMedCrossRef
24.
Zurück zum Zitat Zannad F, Briançon S, Jullière Y et al (1999) Incidence, clinical and etiological features and outcomes of advanced chronic heart failure: the EPICAL STUDY. J Am Coll Cardiol 33:734–742PubMedCrossRef Zannad F, Briançon S, Jullière Y et al (1999) Incidence, clinical and etiological features and outcomes of advanced chronic heart failure: the EPICAL STUDY. J Am Coll Cardiol 33:734–742PubMedCrossRef
Metadaten
Titel
Reverse remodelling through exercise training is more pronounced in non-ischemic heart failure
verfasst von
Charles Delagardelle, MD
Patrick Feiereisen, MSc
Michel Vaillant, PhD
Georges Gilson, PhD
Yves Lasar, MD
Jean Beissel, MD
Daniel R. Wagner, MD, PhD
Publikationsdatum
01.12.2008
Verlag
D. Steinkopff-Verlag
Erschienen in
Clinical Research in Cardiology / Ausgabe 12/2008
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-008-0698-x

Weitere Artikel der Ausgabe 12/2008

Clinical Research in Cardiology 12/2008 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.